Hormone replacement therapy (HRT) - Risks and benefits

International Journal of Epidemiology

Volumn 30, Issue 3, 2001, Pages 423-426

  Barrett Connor, Elizabeth ^a   Stuenkel, Cynthia A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; TAMOXIFEN;

ALZHEIMER DISEASE; AMNESIA; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COGNITION; COLON CANCER; DEMENTIA; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; FEMALE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; OVARIECTOMY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; VERTEBRA FRACTURE;

EID: 0034959798     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/30.3.423     Document Type: Review

References (45)

1. Symptom relief and side effects of postmenopausal hormones: Results from the Postmenopausal Estrogen/Progestin Interventions Trial
2. A prospective population-based study of menopausal symptoms
3. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections
4. Hormone replacement therapy, heart disease, and other considerations
5. Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
6. Estrogen replacement therapy: A 10-year prospective study in the relationship to osteoporosis
7. Prevention of spinal osteoporosis in oophorectomized women
8. Treatment of postmenopausal osteoporosis with transdermal estrogen
9. HRT and Vit D in prevention of non-vertebral fracures inpostmenopausal women; a 5 year randomized trial
10. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
11. The effect of HRT on fracture risk: Results of a 4-year randomized trial of 2,763 postmenopausal women
12. Timing of postmenopausal estrogen for optimal bone mineral density
13. The effect of low-dose continuous estrogen and progesterone with calcium and vitamin D on bone in elderly women. A randomized, controlled trial
14. Calcium potentiates the effect of estrogen and calcitonin on bone mass: Review and analysis
15. Protective effects of estrogen on the cardiovascular system
16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
17. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
18. Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease
19. Statement on preliminary trends in the Women's Health Initiative
20. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
21. Breast cancer risk and duration of estrogen use: The role of study design in meta-analysis
22. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: Transdermal matrix patch versus oral estrogen therapy
23. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
24. Estrogen replacement therapy in women with previous breast cancer
25. Hormone replacement therapy and risk of breast cancer with a favorable histology: Results of the Iowa Women's Health Study
26. Breast cancer risk of following long-term oestrogen- and oestrogen- progestin-replacement therapy
27. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
28. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
29. Effects of estrogen and estrogen-progestin on mammographic parenchymal density
30. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study
31. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
32. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
33. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomized trial among hysterectomised women
34. Hormone replacement therapy and breast cancer risk in a nationally representative cohort
35. Hormone replacement therapy and endometrial cancer risk: A meta-analysis
36. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
37. Estrogen replacement therapy and colon cancer: A clinical review
38. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
39. Effect of postmenopausal hormone therapy on cognitive function: The Heart and Estrogen/progestin Replacement Study
40. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease
41. Postmenopausal hormone therapy increases risk for venous thromboembolic disease
42. Effect of statins on risk of coronary disease: A meta-analysis of randomized control trials
43. Pharmacological management of osteoporosis in postmenopausal women: A comparative review
44. Design of the Women's Health Initiative clinical trial and observational study
45. Hormone replacement therapy and cardiovascular disease: The case for a randomized controlled trial